Using anti-PLAG-neutralizing antibodies, the function of PLAGs was confirmed in CLEC-2 binding, platelet aggregation, and tumor emboli formation indicating that simultaneous inhibition of PLAGs is efficient to block PDPN-mediated tumor growth and metastasis (210). The gene discussed is PDPN; the disease is neoplasm.